10X Genomics
Yahoo Finance • 3 months ago
Zoom Video Communications Faces Major Sell-Off in Cathie Wood's Latest Portfolio Update
Insight into ARK Investment Management's Q2 2024 Moves Cathie Wood, the visionary behind ARK Investment Management, recently disclosed her 13F filings for the second quarter of 2024. With over four decades of experience in investment mana... Full story
Yahoo Finance • 11 months ago
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now. If you want to skip our introduction to the genomics industry and all the latest trends, then take a look at 5 Best Genomics Stocks To Buy Now. If there's one t... Full story
Yahoo Finance • 11 months ago
10x Genomics and NIH CARD to Create Comprehensive Single Cell Atlas of the Human Brain
PLEASANTON, Calif., Dec. 7, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today a collaboration with theNIH Intramural Center for Alzheimer's and Related Dementias (NIH CARD)... Full story
Yahoo Finance • 12 months ago
Q3 2023 10X Genomics Inc Earnings Call
Participants Cassie Corneau; Manager of IR and Strategic Finance; 10x Genomics, Inc. Justin J. McAnear; CFO; 10x Genomics, Inc. Serge Saxonov; Co-Founder, CEO & Director; 10x Genomics, Inc. Daniel Anthony Arias; MD & Senior Analyst; St... Full story
Yahoo Finance • last year
10x Genomics to Present at the Stephens 25th Annual Conference
PLEASANTON, Calif., Nov. 1, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the Stephens 25th An... Full story
Yahoo Finance • last year
Study Enabled by 10x Genomics Single Cell and Spatial Technologies Explains Why Immunotherapy is More Effective for Certain Brain Tumors Than Others
Researchers uncover mechanisms behind divergent responses to immune checkpoint blockade between primary and metastatic brain tumors PLEASANTON, Calif., Sept. 5, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cel... Full story
Yahoo Finance • last year
Why Shares of NanoString Technologies Are Falling Thursday
Shares of NanoString Technologies (NASDAQ: NSTG) were down more than 16% Thursday morning and were down as much as 28.3% earlier in the day after the life sciences company lost a patent ruling in Germany. NanoString makes instruments and s... Full story
Yahoo Finance • 2 years ago
10x Genomics, Inc. (NASDAQ:TXG) Is Expected To Breakeven In The Near Future
10x Genomics, Inc. (NASDAQ:TXG) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. 10x Genomics, Inc., a life science technology company, develops and sells instruments, consum... Full story
Yahoo Finance • 2 years ago
10x Genomics to Host Investor Day on December 8, 2022
PLEASANTON, Calif., Oct. 31, 2022 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG) today announced it will host an Investor Day on December 8, 2022 at the company's headquarters in Pleasanton, CA starting at 9:00 a.m. Pacific Time. The event wil... Full story
Yahoo Finance • 2 years ago
Pacific Biosciences' Tools Expansion Doesn't Guarantee Success
Recent announcements are likely better news for 10x Genomics and Twist Bioscience than for the DNA-sequencing pioneer. Continue reading... Full story
- TWST
Mentioned:
Yahoo Finance • 2 years ago
Billionaire Ken Griffin is Selling These 10 Stocks in 2022
In this article, we discuss the 10 stocks billionaire Ken Griffin is selling in 2022. If you want to skip our detailed analysis of Griffon’s investment philosophy, hedge fund returns, and history, go directly to Billionaire Ken Griffin is... Full story
Yahoo Finance • 2 years ago
10x Genomics Reports First Quarter 2022 Financial Results
Q1 2022 revenue growth of 8% over prior year PLEASANTON, Calif., May 4, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the first quarter ended March 31, 2022. 10x Genomics Logo (PRNewsfoto/10x G... Full story
Yahoo Finance • 3 years ago
Here’s Why You Must Consider Investing in 10x Genomics (TXG)
ClearBridge Investments, an investment management firm, published its “All Cap Growth Strategy” fourth quarter 2021 investor letter – a copy of which can be downloaded here. The ClearBridge All Cap Growth Strategy underperformed its Russel... Full story
